746 related articles for article (PubMed ID: 26227219)
1. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
[TBL] [Abstract][Full Text] [Related]
2. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
3. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion.
Zhan JW; Jiao DM; Wang Y; Song J; Wu JH; Wu LJ; Chen QY; Ma SL
Thorac Cancer; 2017 Sep; 8(5):461-470. PubMed ID: 28660665
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
5. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
6. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
7. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
8. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.
Karatas OF; Suer I; Yuceturk B; Yilmaz M; Oz B; Guven G; Cansiz H; Creighton CJ; Ittmann M; Ozen M
BMC Cancer; 2016 Nov; 16(1):853. PubMed ID: 27816053
[TBL] [Abstract][Full Text] [Related]
10. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
11. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
12. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
13. Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study.
Mitra R; Lin CC; Eischen CM; Bandyopadhyay S; Zhao Z
RNA; 2015 Jun; 21(6):1055-65. PubMed ID: 25852169
[TBL] [Abstract][Full Text] [Related]
14. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
15. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
Jiao DM; Yan L; Wang LS; Hu HZ; Tang XL; Chen J; Wang J; Li Y; Chen QY
PLoS One; 2017; 12(2):e0172470. PubMed ID: 28231299
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
17. MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.
Xu K; Shen K; Liang X; Li Y; Nagao N; Li J; Liu J; Yin P
Oncotarget; 2016 Nov; 7(46):75118-75129. PubMed ID: 27738333
[TBL] [Abstract][Full Text] [Related]
18. Altered Plasma MicroRNA Expression in Patients with Mitral Chordae Tendineae Rupture.
Bulent Vatan M; Kalaycı Yigin A; Akdemir R; Tarik Agac M; Akif Cakar M; Aksoy M; Tatli E; Kilic H; Gunduz H; Guzel D; Karacan K
J Heart Valve Dis; 2016 Sep; 25(5):580-588. PubMed ID: 28238240
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
Zekri AN; El-Sisi ER; Youssef ASE; Kamel MM; Nassar A; Ahmed OS; El Kassas M; Barakat AB; Abd El-Motaleb AI; Bahnassy AA
PLoS One; 2018; 13(3):e0193709. PubMed ID: 29534065
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel circulating miRNAs biomarkers for healthy obese and lean children.
Ma F; Cao D; Liu Z; Li Y; Ouyang S; Wu J
BMC Endocr Disord; 2023 Oct; 23(1):238. PubMed ID: 37904219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
